Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Prostatype Genomics AB TO 2 registered at the Swedish Companies Registration Office

Prostatype Genomics AB (”Prostatype Genomics” or ”the Company”) today announces that the recently executed warrant exercise of warrants of series TO 2 has been registered at the Companies Registration Office.In total 2,622 warrants of series TO 2 were exercised during the exercise period 9-30 March 2023. The Swedish Companies Registration Office has now registered the warrant exercise and the total number of shares after the registration amounts to 22,862,119 shares and the share capital amounts to SEK 1,371,727.14. The conversion from interim shares to ordinary shares is expected to

Contract award DOF group

The DOF group is pleased to announce a new 3-years firm contract for the AHTS Skandi Vega with the current charterer Equinor Energy AS. The award, which also include 2 x 1 year options, will commence in direct continuation of the current contract. Skandi Vega is one of the largest AHTS vessels in the world and have been operating for Equinor since delivery in 2010. DOF is delighted to continue the long-term partnership with Equinor and the new contract is a proof of the value the vessel and its crew brings to this partnership.   Mons S. Aase, DOF Group CEO say: DOF is very pleased to

P CAPITAL ANNOUNCES NAV OF P CAPITAL PARTNERS ALPHA

Press release   Stockholm,11 April 2023     P Capital today announces that, at the close of business on 31 March 2023, the Net Asset Value of P Capital Partners Alpha participation loan amounted to SEK 556,952 per debenture. Ordinary income of SEK 14,959 per debenture will be distributed to debenture holders on 18 April 2023. A partial repayment of the participation loan debentures amounting to SEK 214,000 per debenture will be made on 28 April 2023. P Capital Partners Alpha’s assets are composed of 100 per cent privately issued corporate loans. During the quarter no

NOTICE CONVENING THE 2023 ANNUAL GENERAL MEETING

Genovis AB will hold its Annual General Meeting of Shareholders at 5:00 p.m. on Tuesday, May 16, 2023 at Medicon Village Scheeletorget 1, Lund (restaurant Inspira/Auditorium). Participants may register upon arrival at the reception desk by the Auditorium. 4:30 p.m. – 4:50 p.m. Registration     5:00 pm Annual General Meeting convened Right to participate. Registration Shareholders who are registered in the register of shareholders maintained by Euroclear Sweden AB on May 8, 2023 and who have notified the company of their intention to attend the Annual General Meeting by no later

Lehto Group Plc: Lehto to build Makita's Finnish headquarters and large warehouse facilities in Tuusula

Lehto Group PlcInside information11 April, 2023 at 13.30 (Finnish time) Lehto has signed an agreement to build  Finnish headquarters  and sizeable warehouses for power tool manufacturer Makita in Rykmentinpuisto area in Tuusula.The premises are built on two floors and the building complex comprises a total of more than 24,000 square meters. The largest sections in the building are storage spaces, but the premises will also include offices, showroom, demo area and maintenance facilities. The building uses ecological geothermal heat for heating and ground cooling for cooling.

P CAPITAL ANNOUNCES NAV OF P CAPITAL PARTNERS III

Press release Stockholm, 11 April 2023 P Capital today announces that, at the close of business on 31 March 2023, the Net Asset Value per participation loan debentures of P Capital Partners III, was SEK 243,433 for series A and SEK 6,101,075 for series B. No ordinary income will be distributed for the quarter. A partial repayment of the participation loan debentures amounting to SEK 35,000 per series A debenture and SEK 875,000 per series B debenture will be made on 28 April 2023. P Capital Partners III’s assets are composed of 3.5 per cent publicly traded corporate bonds and 96.

P CAPITAL ANNOUNCES NAV OF P CAPITAL PARTNERS IV

Press release Stockholm,11 April 2023   P Capital today announces that, at the close of business on 31 March 2023, the Net Asset Value, per participation loan debentures of P Capital Partners IV, is EUR 98.43 for series A1. Ordinary income of EUR 3.32 per series A1 participation loan debentures will be distributed to debenture holders on 25 April 2023. No repayment of capital will be distributed to debenture holders for the quarter. P Capital Partners IV’s assets are composed of 95.8 per cent privately issued corporate loans and 4.2 per cent publicly traded corporate bonds.

P CAPITAL ANNOUNCES NAV OF P CAPITAL PARTNERS IV B

Press release   Stockholm,11 April 2023     P Capital today announces that, at the close of business on 31 March 2023, the Net Asset Value per participation loan debentures of P Capital Partners IV B, is EUR 95.12 for series A1 and EUR 951.55 for series B. Ordinary income of EUR 2.84 per series A1 participation loan debentures and EUR 28.8 per series B participation loan debenture will be distributed on 25 April 2023. No repayment of capital will be distributed to debenture holders for the quarter. P Capital Partners IV B’s assets are composed of 95.8 per cent private

COMMUNIQUE FROM THE ANNUAL GENERAL MEETING OF STENOCARE

STENOCARE A/SNASDAQ FIRST NORTH GROWTH MARKET, DENMARKTICKER:  STENOOn 11 April 2023 annual general meeting of shareholders of STENOCARE A/S, CVR no. 39024705, was held at Lund Elmer Sandager Law Firm, Kalvebod Brygge 39-41, DK-1560 København V with the following agenda: Agenda: 1. Appointment of a chairman of the meeting 2. Report of the chairman of the board of directors 3. Presentation of the annual report together with a resolution for its adoption 4. Resolution to appropriate the profit or cover the loss 5. Election of members of the board of directors 6.

Rights issue subscription period ending 12 April 2023; subscription possible via form

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND OR IN ANY OTHER JURISDICTION WHERE SUCH RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES. FOR MORE INFORMATION, SEE THE SECTION IMPORTANT INFORMATION BELOW. Hørsholm, Denmark, 11 April 2023 – On 3 March 2023, the Board of Directors of Expres2ion Biotech Holding AB (“ExpreS2ion” or the “Company”) resolved, conditional upon

Tietoevry's first-quarter results on 4 May – invitation to a teleconference

Tietoevry Corporation           PRESS RELEASE          11 April 2023, 1.00 p.m. EET Tietoevry will publish its results for 1 January–31 March 2023 on Thursday 4 May 2023 at 8.00 am EEST (7.00 am CEST, 6.00 am UK time). A teleconference for analysts and media will be held at 10.00 am EEST (9.00 am CEST, 8.00 am UK time). Kimmo Alkio, President and CEO, and Tomi Hyryläinen, CFO, will present the results online in English. The presentation  can be followed on Tietoevry's website.  To take part in the questions

Invitation to presentation of Bulten’s Q1 report 2023

Bulten’s report for the first quarter 2023 will be published on Tuesday April 25, at 1:30 p.m. CEST.A live presentation for analysts, media and investors will be held the same day, at 3:30 p.m. CEST, where President and CEO Anders Nyström and CFO Anna Åkerblad will be commenting the result. The presentation will be held in English and include a Q&A session.Date: Tuesday, April 25.Time: The report will be published at 1:30 p.m. CEST and the webcasted telephone conference starts at 3:30 p.m. CEST.The report will be available on Bulten’s website: https://www.bulten.com/en/IR?

Invitation to the presentation of first quarter 2023 accounts, Thursday 4 May

SpareBank 1 SR-Bank's first quarter 2023 accounts will be released at 7:30 a.m. on Thursday 4 May, and we would like to invite you to the following presentations: 8:15 a.m. CET - Presentation in Norwegian, live and webcast Location: SpareBank 1 Markets, Olav V's gate 5, Oslo. The presentation will be held by CEO Benedicte Schilbred Fasmer and CFO Inge Reinertsen. It will also be available as a webcast on the Investor Relations pages at www.sr-bank.no/ir. Breakfast is served from 08.00 a.m. 1:30 p.m. CET - Digital presentation for analysts and investors in English CEO

Pilot study finds metabolic alterations related to sexual and physical abuse – Further research into oxidative stress and transsulfuration in the context of trauma is needed

A pilot study conducted at the University of Eastern Finland found metabolites related to oxidative stress and the transsulfuration pathway of one-carbon metabolism to be associated with a history of sexual or physical abuse in depressed adolescent outpatients. Oxidative stress and transsulfuration are closely connected and regulate each other’s functions, and they play a role in inflammation, which is also recognized as a possible mechanism of trauma. The results were published in a peer-reviewed scientific journal, the European Journal of Psychotraumatology, in a special issue entitled “

PLAGAZI ANNOUNCES MICHAEL ENGSTED AS CHIEF SALES OFFICER (CSO)

Plagazi can excitedly declare that Michael Engsted, previously Managing Director of Plagazi’s U.K. branch, has transitioned into the role of Chief Sales Officer (CSO), marking a much-needed addition to Plagazi’s management team. Michael brings with him a wealth of knowledge of the industrial gases, renewable energy and waste-to-energy markets, particularly from a sales and project development perspective, which will bolster the overall sales growth and client-nurturing capacity of Plagazi.Michael Engsted has previously been actively involved in Plagazi as a Managing Director, building and

French flavors and more services for Kallebäcks Terrasser

With Tarte Flambée as its speciality and other delicious French flavors, the restaurant Valentinas is opening in Kallebäcks Terrasser in the fall. And already in the spring, the service offering will improve in the area when a smaller convenience store will welcome its first customers.So far, three blocks containing just over 500 apartments have welcomed new tenants to Kallebäcks Terrasser. In May and June, a further two blocks will be filled with new residential tenants and businesses.“We are very much looking forward to creating a wonderful new meeting place in the area, a nice and

Invitation – Presentation of Q1 2023 Interim Report

Boliden will announce its Interim Report for the first quarter 2023 on Tuesday 25 April at 07.45 (CET). A press and analyst conference will be held on the same day at 09.30, which can be followed via webcast and telephone. The report will be presented by Boliden’s President and CEO Mikael Staffas, and CFO Håkan Gabrielsson. To participate, please register 5 minutes before the opening of the conference via the link below. After the registration you will be provided with phone numbers and a conference ID to access the conference. If you wish to ask a question, please dial *5 on your

ExpreS2ion publishes video presentation

Hørsholm, Denmark, 11 April 2023 – ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion") announces that a filmed company presentation by CEO Bent U. Frandsen in which he presents provides an update on development of ExpreS2ion’s leading pipeline assets, potential markets and the 2023 Rights Issue, is now available on the company’s website.The presentation can be found on the Company’s investor website via the following link: https://investor.expres2ionbio.com/presentations/ Certified AdviserSvensk Kapitalmarknadsgranskning AB

Freyr Battery and Stena Recycling sign agreement

In connection with the opening of its battery recycling facility, Stena Recycling announces a new industrial scale customer within battery production. Stena Recycling and Freyr Battery have entered an agreement regarding recycling services of scrap battery material from Freyr’s customer qualification plant in Norway. In cooperation with its strategic partner Østbø, Stena Recycling will provide a total waste management solution. “Recycling of batteries and using the recovered battery materials is one of the core strategies of Freyr. The agreement fulfills our high demands regarding

Stendörren Fastigheter AB (publ) appoints ABG Sundal Collier as liquidity provider

Press release 11 April 2023 Stendörren Fastigheter AB (publ) (“Stendörren” or the “Company”) has appointed ABG Sundal Collier (“ABGSC”) as liquidity provider for the Company’s shares listed on Nasdaq Stockholm. The commitment takes place within the framework of Nasdaq Stockholm’s rules on liquidity providers where ABGSC undertakes to continuously during the opening hours quote prices for Stendörren’s share in accordance with the at all time prevailing minimum requirements for liquidity providers set out by Nasdaq Stockholm aiming at improving the liquidity of the share and reduce the

Notice to the Annual General Meeting of Duni AB (publ), May 16, 2023

In accordance with the listing agreement with Nasdaq Stockholm, Duni AB hereby also announces, by issuing a press release, the content of the notice concerning Duni’s Annual General Meeting on May 16, 2023.   The shareholders of Duni AB (publ), Reg. No. 556536-7488, are hereby invited to attend the Annual General Meeting to be held on Tuesday, 16 May 2023, at 15.00 p.m. at Glasklart, Dockplatsen 1, in Malmö, Sweden. Registration starts at 14.15 p.m.   The board of directors has decided that shareholders shall be able to exercise their voting rights at the annual general meeting

BioStock: One-on-one with Annexin Pharmaceuticals' new CFO

Biotech company Annexin Pharmaceuticals has had intensive months with the phase II study in RVO as well as investments in the cancer area. Most recently, the company announced that it had recruited Susanne Andersson as the new CFO and as part of the management team. BioStock spoke to Susanne in connection with her appointment today, to learn more about her background and expectations for the role at Annexin.Read the interview with Annexin Pharmaceuticals' new CFO Susanne Andersson here: https://www.biostock.se/en/2023/04/one-on-one-with-annexin-pharmaceuticals-new-cfo/ This is a press

There are no items matching the current filter
There are no more items matching the current filter
Back to top